Sector
Health
Historical revenue, net income, net margin and earnings per share of Johnson & Johnson, year by year from 2010 to 2025. Market data, amounts in US dollars.
Revenue, net income, net margin, earnings per share (EPS) and revenue growth. Amounts in USD.
| Year | Revenue | Net income | Net margin | BPA | Revenue growth |
|---|---|---|---|---|---|
| 2010 | 61,59 billion $ | 13,33 billion $ | 21,6 % | 4,86 $ | n/d |
| 2011 | 65,03 billion $ | 9,67 billion $ | 14,9 % | 3,54 $ | +5,6 % |
| 2012 | 67,22 billion $ | 10,85 billion $ | 16,1 % | 3,91 $ | +3,4 % |
| 2013 | 71,31 billion $ | 13,83 billion $ | 19,4 % | 4,90 $ | +6,1 % |
| 2014 | 74,33 billion $ | 16,32 billion $ | 22,0 % | 5,86 $ | +4,2 % |
| 2015 | 70,07 billion $ | 15,41 billion $ | 22,0 % | 5,57 $ | -5,7 % |
| 2016 | 71,89 billion $ | 16,54 billion $ | 23,0 % | 6,08 $ | +2,6 % |
| 2017 | 76,45 billion $ | 1,30 billion $ | 1,7 % | 0,48 $ | +6,3 % |
| 2018 | 81,58 billion $ | 15,30 billion $ | 18,8 % | 5,75 $ | +6,7 % |
| 2019 | 82,06 billion $ | 15,12 billion $ | 18,4 % | 5,74 $ | +0,6 % |
| 2020 | 82,58 billion $ | 14,71 billion $ | 17,8 % | 5,59 $ | +0,6 % |
| 2021 | 78,74 billion $ | 20,88 billion $ | 26,5 % | 7,93 $ | -4,7 % |
| 2022 | 79,99 billion $ | 17,94 billion $ | 22,4 % | 6,83 $ | +1,6 % |
| 2023 | 85,16 billion $ | 35,15 billion $ | 41,3 % | 13,88 $ | +6,5 % |
| 2024 | 88,82 billion $ | 14,07 billion $ | 15,8 % | 5,84 $ | +4,3 % |
| 2025 | 94,19 billion $ | 26,80 billion $ | 28,5 % | 11,03 $ | +6,0 % |
Graphical representation of annual amounts (in USD).
Valuation and profitability; price ratios calculated based on the price of 13/11/2026.